Stellantis completed the acquisition of a 33.3% stake in Symbio from Faurecia and Michelin.

Stellantis, an automakers and a mobility provider, completed the acquisition of a 33.3% stake in Symbio, a hydrogen company, from Faurecia, an automotive technology company and Michelin, a tyre manufacturing company. Financial terms were not disclosed. “Symbio’s technical roadmap perfectly matches with Stellantis’ hydrogen roll-out plans in Europe and in the US. This move will foster the speed of development to bring low emission products to our customers, beyond traditional electric vehicles. We’re grateful to the teams at Faurecia, Michelin and Symbio for their commitment to innovation, excellence, and collaboration as we all work to achieve decarbonized mobility,” Carlos Tavares, Stellantis CEO.